News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • U.S. moved to propose a 15% global tariff framework after a Supreme Court ruling, increasing uncertainty for exporters.
  • EU demanded the U.S. honor agreed tariff ceilings while Switzerland signaled acceptance of prolonged U.S. tariffs under a 15% deal tied to Swiss investment.
  • S&P 500 volatility compressed to its tightest weekly Bollinger Bands since 2019, signaling an imminent large move and tactical long opportunities.
  • Report says Iran and Russia agreed a €500 million deal for man-portable missiles, escalating geopolitical risk for markets.
  • Dollar General trading near its 52-week high as consumers favor discount channels, prompting tactical long trade ideas.
  • Blue Owl slid near its 52-week low after redemption and financing headlines, drawing buy-the-dip swing trade proposals based on oversold technicals.

Latest Articles

DA Davidson Trims Palo Alto Networks Price Target After Q2; Maintains Buy

DA Davidson Trims Palo Alto Networks Price Target After Q2; Maintains Buy

DA Davidson lowered its price target on Palo Alto Networks to $190 from $210 while keeping a Buy rating after the company’s fiscal second-quarter results. The analyst flagged underwhelming organic next‑generation security annual recurring revenue (ARR) and remaining performance obligations (RPO) upside versus investor expectations, even as several …

FDA Agrees to Review Moderna’s Revised Influenza Vaccine Application

FDA Agrees to Review Moderna’s Revised Influenza Vaccine Application

Moderna announced the U.S. Food and Drug Administration will review a revised application for its seasonal influenza vaccine after the agency rejected the company's initial submission a week earlier. The revised filing requests full approval for adults 50-64 and accelerated approval for those 65 and older, and includes a commitment to a post-market…

IREN: Buy the GPU Transition After the Q2 Capitulation

IREN: Buy the GPU Transition After the Q2 Capitulation

IREN has swung from crypto-dependent volatility toward an AI infrastructure identity. Recent financing, a large Microsoft contract and a 1.4 GW facility coming online give the stock a tangible re-rating path. The trade: a long entry at current levels with a defined stop and target to ride a mid-to-long-term re-rating while respecting execution risk…

StoneX CIO Sells $1.01M in Stock, Exercises Options Amid Strong Q1 Results

StoneX CIO Sells $1.01M in Stock, Exercises Options Amid Strong Q1 Results

StoneX Group Inc. Chief Information Officer Abigail H. Perkins sold 8,000 shares on February 13, 2026, for $1,013,728 and exercised options to acquire 8,000 shares at $27.58 the same day. Following the transactions, Perkins holds 48,259 shares directly and 337 indirectly through her children. The moves come as StoneX trades close to a 52-week high …

Landmark Trial Opens Over Alleged Design of Social Apps to Hook Children

Landmark Trial Opens Over Alleged Design of Social Apps to Hook Children

A California trial opened as a 20-year-old plaintiff alleges Meta Platforms and Google’s YouTube intentionally engineered social apps to addict children, fueling her depression and suicidal thoughts. Lawyers for the plaintiff say internal documents reveal purposeful design choices to capture young users; the tech companies deny the claims and say o…

DraftKings Shares Tick Up After Director Acquires $2.19M Stake

DraftKings Shares Tick Up After Director Acquires $2.19M Stake

DraftKings shares rose modestly in premarket trading after company director Harry Sloan bought 100,000 Class A shares for roughly $2.19 million on February 17, 2026. The purchase, at $21.85 per share, brings Sloan's total stake to 350,219 shares and has been interpreted as a sign of insider confidence.

Premium Daily Contact Lenses Forecast to Drive 2026 Market Recovery

Premium Daily Contact Lenses Forecast to Drive 2026 Market Recovery

Contact lens manufacturers anticipate steadier expansion in 2026 as shoppers increasingly adopt premium daily disposable lenses and global myopia prevalence rises. Industry leaders are positioned to capture higher-margin sales and more frequent repurchases, although price sensitivity and regional weakness present risks to growth.